H. Sung, J. Ferlay, R.L. Siegel, M. Laversanne, I. Soerjomataram, A. Jemal, F. Bray, Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71(3), 209–249 (2021)
C. Rödel, U. Graeven, R. Fietkau, W. Hohenberger, T. Hothorn, D. Arnold, R.D. Hofheinz, M. Ghadimi, H.A. Wolff, M. Lang-Welzenbach, H.R. Raab, C. Wittekind, P. Ströbel, L. Staib, M. Wilhelm, G.G. Grabenbauer, H. Hoffmanns, F. Lindemann, A. Schlenska-Lange, G. Folprecht, R. Sauer, T. Liersch, Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial. Lancet Oncol. 16(8), 979–989 (2015)
A.B. Benson, A.P. Venook, M.M. Al-Hawary, N. Azad, Y.J. Chen, K.K. Ciombor, S. Cohen, H.S. Cooper, D. Deming, I. Garrido-Laguna, J.L. Grem, A. Gunn, J.R. Hecht, S. Hoffe, J. Hubbard, S. Hunt, W. Jeck, K.L. Johung, N. Kirilcuk, S. Krishnamurthi, J.K. Maratt, W.A. Messersmith, J. Meyerhardt, E.D. Miller, M.F. Mulcahy, S. Nurkin, M.J. Overman, A. Parikh, H. Patel, K. Pedersen, L. Saltz, C. Schneider, D. Shibata, J.M. Skibber, C.T. Sofocleous, E. Stotsky-Himelfarb, A. Tavakkoli, C.G. Willett, K. Gregory, L. Gurski, Rectal cancer, version 2.2022, NCCN clinical practice guidelines in oncology. J. Natl. Compr. Canc. Netw. 20(10), 1139–1167 (2022)
Article CAS PubMed Google Scholar
A.B. Benson, A.P. Venook, M.M. Al-Hawary, M.A. Arain, Y.J. Chen, K.K. Ciombor, S. Cohen, H.S. Cooper, D. Deming, L. Farkas, I. Garrido-Laguna, J.L. Grem, A. Gunn, J.R. Hecht, S. Hoffe, J. Hubbard, S. Hunt, K.L. Johung, N. Kirilcuk, S. Krishnamurthi, W.A. Messersmith, J. Meyerhardt, E.D. Miller, M.F. Mulcahy, S. Nurkin, M.J. Overman, A. Parikh, H. Patel, K. Pedersen, L. Saltz, C. Schneider, D. Shibata, J.M. Skibber, C.T. Sofocleous, E.M. Stoffel, E. Stotsky-Himelfarb, C.G. Willett, K.M. Gregory, L.A. Gurski, Colon cancer, version 2.2021, NCCN clinical practice guidelines in oncology. J. Natl. Compr. Canc. Netw. 19(3), 329–359 (2021)
E. Raymond, S. Faivre, J.M. Woynarowski, S.G. Chaney, Oxaliplatin: mechanism of action and antineoplastic activity. Semin. Oncol. 25(2 Suppl 5), 4–12 (1998)
R. Ranasinghe, M.L. Mathai, A. Zulli, Cisplatin for cancer therapy and overcoming chemoresistance. Heliyon 8(9), e10608 (2022)
Article CAS PubMed PubMed Central Google Scholar
E. De Mattia, E. Cecchin, G. Toffoli, Pharmacogenomics of intrinsic and acquired pharmacoresistance in colorectal cancer: toward targeted personalized therapy. Drug. Resist. Updat. 20, 39–70 (2015)
W.D. Fairlie, A.G. Moore, A.R. Bauskin, P.K. Russell, H.P. Zhang, S.N. Breit, MIC-1 is a novel TGF-beta superfamily cytokine associated with macrophage activation. J. Leukoc. Biol. 65(1), 2–5 (1999)
Article CAS PubMed Google Scholar
J. Strelau, A. Schober, A. Sullivan, L. Schilling, K. Unsicker, Growth/differentiation factor-15 (GDF-15), a novel member of the TGF-beta superfamily, promotes survival of lesioned mesencephalic dopaminergic neurons in vitro and in vivo and is induced in neurons following cortical lesioning. J. Neural. Transm. Suppl. 65, 197–203 (2003)
S. Muniyan, R. Pothuraju, P. Seshacharyulu, S.K. Batra, Macrophage inhibitory cytokine-1 in cancer: beyond the cellular phenotype. Cancer Lett. 536, 215664 (2022)
Article CAS PubMed PubMed Central Google Scholar
S.F. Wang, Y.L. Chang, W.L. Fang, A.F. Li, C.F. Chen, T.S. Yeh, G.Y. Hung, K.H. Huang, H.C. Lee, Growth differentiation factor 15 induces cisplatin resistance through upregulation of xCT expression and glutathione synthesis in gastric cancer. Cancer Sci. 114(8), 3301–3317 (2023)
Article CAS PubMed PubMed Central Google Scholar
R. He, J. Shi, D. Xu, J. Yang, Y. Shen, Y.S. Jiang, L. Tao, M. Yang, X. Fu, J.Y. Yang, D. Liu, Y. Huo, X. Shen, P. Lu, N. Niu, Y.W. Sun, J. Xue, W. Liu, SULF2 enhances GDF15-SMAD axis to facilitate the initiation and progression of pancreatic cancer. Cancer Lett. 538, 215693 (2022)
Article CAS PubMed Google Scholar
Z. Wang, S. Wang, Z. Jia, Y. Hu, D. Cao, M. Yang, L. Liu, L. Gao, S. Qiu, W. Yan, Y. Li, J. Luo, Y. Geng, J. Zhang, Z. Li, X. Wang, M. Li, R. Shao, Y. Liu, YKL-40 derived from infiltrating macrophages cooperates with GDF15 to establish an immune suppressive microenvironment in gallbladder cancer. Cancer Lett. 563, 216184 (2023)
Article CAS PubMed Google Scholar
S. Yu, Q. Li, Y. Yu, Y. Cui, W. Li, T. Liu, F. Liu, Activated HIF1α of tumour cells promotes chemoresistance development via recruiting GDF15-producing tumour-associated macrophages in gastric cancer. Cancer Immunol. Immunother. 69(10), 1973–1987 (2020)
Article CAS PubMed Google Scholar
H. Ji, H.W. Lu, Y.M. Li, L. Lu, J.L. Wang, Y.F. Zhang, H. Shang, Twist promotes invasion and cisplatin resistance in pancreatic cancer cells through growth differentiation factor 15. Mol. Med. Rep. 12(3), 3841–3848 (2015)
Article CAS PubMed Google Scholar
D. Shimizu, T. Ishikawa, Y. Ichikawa, S. Togo, Y. Hayasizaki, Y. Okazaki, P.V. Danenberg, H. Shimada, Prediction of chemosensitivity of colorectal cancer to 5-fluorouracil by gene expression profiling with cDNA microarrays. Int. J. Oncol. 27(2), 371–376 (2005)
Y. Du, Y. Ma, Q. Zhu, Y. Fu, Y. Li, Y. Zhang, M. Li, F. Feng, P. Yuan, X. Wang, GDF15 negatively regulates chemosensitivity via TGFBR2-AKT pathway-dependent metabolism in esophageal squamous cell carcinoma. Front. Med. 17(1), 119–131 (2023)
Z. Cong, G. Ye, Z. Bian, M. Yu, M. Zhong, Jagged-1 attenuates LPS-induced apoptosis and ROS in rat intestinal epithelial cells. Int. J. Clin. Exp. Pathol. 11(8), 3994–4003 (2018)
CAS PubMed PubMed Central Google Scholar
Z. Zheng, M. Wu, H. Li, W. Xu, M. Yang, K. Pan, Y. Ni, T. Jiang, H. Zheng, X. Jin, Y. Zhang, L. Ding, J. Fu, Downregulation of AC092894.1 promotes oxaliplatin resistance in colorectal cancer via the USP3/AR/RASGRP3 axis. BMC Med. 21(1), 132 (2023)
Article CAS PubMed PubMed Central Google Scholar
L. Chen, Z. Dai, C. Ge, D. Huang, X. Zhou, K. Pan, W. Xu, J. Fu, J.L. Du, Specific metabolic response of patient-derived organoids to curcumin of colorectal cancer. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 1203, 123260 (2022)
Article CAS PubMed Google Scholar
W.R. Becker, S.A. Nevins, D.C. Chen, R. Chiu, A.M. Horning, T.K. Guha, R. Laquindanum, M. Mills, H. Chaib, U. Ladabaum, T. Longacre, J. Shen, E.D. Esplin, A. Kundaje, J.M. Ford, C. Curtis, M.P. Snyder, W.J. Greenleaf, Single-cell analyses define a continuum of cell state and composition changes in the malignant transformation of polyps to colorectal cancer. Nat. Genet. 54(7), 985–995 (2022)
Article CAS PubMed PubMed Central Google Scholar
A.W.J. van Renterghem, J. van de Haar, E.E. Voest, Functional precision oncology using patient-derived assays: bridging genotype and phenotype. Nat. Rev. Clin. Oncol. 20(5), 305–317 (2023)
H. Xu, D. Jiao, A. Liu, K. Wu, Tumour organoids: applications in cancer modeling and potentials in precision medicine. J. Hematol. Oncol. 15(1), 58 (2022)
Article PubMed PubMed Central Google Scholar
W. Xiong, D. Li, Y. Feng, C. Jia, X. Zhang, Z. Liu, CircLPAR1 promotes neuroinflammation and oxidative stress in APP/PS1 mice by inhibiting SIRT1/Nrf-2/HO-1 axis through destabilizing GDF-15 mRNA. Mol. Neurobiol. 60(4), 2236–2251 (2023)
Article CAS PubMed Google Scholar
Y. Wang, C. Chen, J. Chen, T. Sang, H. Peng, X. Lin, Q. Zhao, S. Chen, T. Eling, X. Wang, Overexpression of NAG-1/GDF15 prevents hepatic steatosis through inhibiting oxidative stress-mediated dsDNA release and AIM2 inflammasome activation. Redox. Biol. 52, 102322 (2022)
Article CAS PubMed PubMed Central Google Scholar
H. Huang, L. Zhu, B.R. Reid, G.P. Drobny, P.B. Hopkins, Solution structure of a cisplatin-induced DNA interstrand cross-link. Science 270(5243), 1842–1845 (1995)
Article ADS CAS PubMed Google Scholar
M. Rojo de la Vega, E. Chapman, D.D. Zhang, NRF2 and the hallmarks of cancer. Cancer Cell. 34(1), 21–43 (2018)
Article CAS PubMed Google Scholar
A.I. Rojo, O.N. Medina-Campos, P. Rada, A. Zúñiga-Toalá, A. López-Gazcón, S. Espada, J. Pedraza-Chaverri, A. Cuadrado, Signaling pathways activated by the phytochemical nordihydroguaiaretic acid contribute to a Keap1-independent regulation of Nrf2 stability: role of glycogen synthase kinase-3. Free Radic. Biol. Med. 52(2), 473–487 (2012)
Article CAS PubMed Google Scholar
T. Liu, Y.F. Lv, J.L. Zhao, Q.D. You, Z.Y. Jiang, Regulation of Nrf2 by phosphorylation: consequences for biological function and therapeutic implications. Free Radic. Biol. Med. 168, 129–141 (2021)
Article CAS PubMed Google Scholar
S.E. Mullican, X. Lin-Schmidt, C.N. Chin, J.A. Chavez, J.L. Furman, A.A. Armstrong, S.C. Beck, V.J. South, T.Q. Dinh, T.D. Cash-Mason, C.R. Cavanaugh, S. Nelson, C. Huang, M.J. Hunter, S.M. Rangwala, GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates. Nat. Med. 23(10), 1150–1157 (2017)
Article CAS PubMed Google Scholar
P.J. Emmerson, F. Wang, Y. Du, Q. Liu, R.T. Pickard, M.D. Gonciarz, T. Coskun, M.J. Hamang, D.K. Sindelar, K.K. Ballman, L.A. Foltz, A. Muppidi, J. Alsina-Fernandez, G.C. Barnard, J.X. Tang, X. Liu, X. Mao, R. Siegel, J.H. Sloan, P.J. Mitchell, B.B. Zhang, R.E. Gimeno, B. Shan, X. Wu, The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL. Nat. Med. 23(10), 1215–1219 (2017)
Article CAS PubMed Google Scholar
Z. Zhao, J. Zhang, L. Yin, J. Yang, Y. Zheng, M. Zhang, B. Ni, H. Wang, Upregulated GDF-15 expression facilitates pancreatic ductal adenocarcinoma progression through orphan receptor GFRAL. Aging (Albany NY) 12(22), 22564–22581 (2020)
Comments (0)